2020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendations

2020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendations

Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy, excellent safety profile, and truncated treatment duration, has revolutionized the paradigm of hepatitis C treatme...

Full description

Bibliographic Details
Main Authors: Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, Tsung-Hui Hu, Chung-Feng Huang, Yi-Hsiang Huang, Chao-Hung Hung, Chun-Yen Lin, Chen-Hua Liu, Chun-Jen Liu, Cheng-Yuan Peng, Han-Chieh Lin, Jia-Horng Kao, Wan-Long Chuang
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Journal of the Formosan Medical Association
Subjects:
HCV
DAA
Taiwan
TASL
Consensus
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664620301236

Internet

http://www.sciencedirect.com/science/article/pii/S0929664620301236

Similar Items